Government of Colombia Declares Clever Leaves Colombia as ‘Project of National and Strategic Interest’

Priority Status Highlights Government Support; Accelerates Execution of Strategic Projects and Regulatory Processes NEW YORK, Sept. 23, 2020 (GLOBE NEWSWIRE) — Clever Leaves (the “Company”), a leading multi-national operator and licensed producer of pharmaceutical-grade cannabinoids, announced today that its Colombian operations have been named a Project of National and Strategic Interests (“PINE”) by the Government of Colombia. […]

One cure for an ailing American economy: Legalize cannabis

America’s next president will face an unprecedented array of challenges, chief among them an economy in ruins and an ugly social divide. Having served in government for nearly three decades, including as Senate majority leader, I know that there’s no silver bullet that can magically solve all of these problems.  However, I’ve also learned that […]

Schultze Special Purpose Acquisition Corp. and Clever Leaves International Inc., a Large-Scale Pharmaceutical-Grade Multi-National Cannabis Operator, to Host Investor Webinar

RYE BROOK, N.Y., Sept. 02, 2020 (GLOBE NEWSWIRE) — Schultze Special Purpose Acquisition Corp. (NASDAQ: SAMA, SAMAW, and SAMAU) (“SAMA”) and Clever Leaves International Inc. (“Clever Leaves”) today announced that the two companies will host a joint investor webinar. The presentation and Q&A session will be held on Thursday, September 10, at 11 AM EDT. […]

Schultze Special Purpose Acquisition Corp. and Clever Leaves International Inc., a Large-Scale Pharmaceutical-Grade Multi-National Cannabis Operator, to Host Investor Webinar Presentation and Q&A Session Scheduled for Thursday, September 10 at 11:00 AM EDT

RYE BROOK, N.Y., Sept. 02, 2020 (GLOBE NEWSWIRE) — Schultze Special Purpose Acquisition Corp. (NASDAQ: SAMA, SAMAW, and SAMAU) (“SAMA”) and Clever Leaves International Inc. (“Clever Leaves”) today announced that the two companies will host a joint investor webinar. The presentation and Q&A session will be held on Thursday, September 10, at 11 AM EDT. […]

Schultze Special Purpose Acquisition Corp. and Clever Leaves International Inc., a Large-Scale Pharmaceutical-Grade Multi-National Cannabis Operator, to Participate in the IPO Edge Forum: Raising Capital in Cannabis – Are SPACs a New Solution? Panel Discussion and Live Q&A Session Scheduled for Sept 2 at 2:00 PM EDT

RYE BROOK, N.Y., Aug. 31, 2020 (GLOBE NEWSWIRE) — Schultze Special Purpose Acquisition Corp. (NASDAQ: SAMA, SAMAW, and SAMAU) (“SAMA”) and Clever Leaves International Inc. (“Clever Leaves”) today announced that Gary Julien, Managing Director, Schultze Asset Management, LP; EVP, Schultze Special Acquisition Corp. and Kyle Detwiler, CEO, Clever Leaves (expected ticker: CLVR) will participate in […]

Clever Leaves’ Portugal Operation Granted License to Cultivate, Sell, and Export Medical Cannabis

 Clever Leaves (the “Company”), a leading multi-national operator and licensed producer of pharmaceutical-grade cannabinoids, announced today it has been granted a license from INFARMED I.P., the Portuguese regulatory authority with oversight over the pharmaceutical industry in Portugal, including medical cannabis, to cultivate, import and export Good Agricultural and Collecting Practice (GACP) quality dried flower, produced from […]

Clever Leaves Appoints David Kastin as General Counsel and Corporate Secretary

NEW YORK, Aug. 19, 2020 (GLOBE NEWSWIRE) — Clever Leaves (the “Company”), a leading multi-national operator and licensed producer of pharmaceutical-grade cannabinoids, announced today the appointment of David M. Kastin as General Counsel and Corporate Secretary. David will oversee all aspects of the Company’s global legal activities and policies while supporting the CEO and Board of Directors […]

Clever Leaves Enters Australian Market with Supply Agreement with Cannatrek

Clever Leaves (the “Company”), a leading multi-national operator (MNO) and licensed producer of pharmaceutical-grade medical cannabinoids, today announced it has entered the Australian market with the arrival of its first white-labeled, semi-finished product shipment to Cannatrek, an Australian seed-to-patient medicinal cannabis producer. The two-year supply agreement includes various CBD oral solution concentrations for distribution through physician […]